Robert L. Nussbaum - 22 Aug 2022 Form 4 Insider Report for Invitae Corp

Role
Chief Medical Officer
Signature
/s/ Thomas R. Brida, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
22 Aug 2022
Net transactions value
$0
Form type
4
Filing time
24 Aug 2022, 21:26:13 UTC
Previous filing
18 Aug 2022
Next filing
15 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVTA Common Stock Award $0 +54,000 +14% $0.000000 450,532 22 Aug 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares issuable upon settlement of a restricted stock unit award that vests in full on August 15, 2023, subject to continued service with the issuer through such vesting date.
F2 Includes an aggregate of 279,380 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.